Cyclic AMP prolongs graft survival by suppressing apoptosis and inflammatory gene expression in acute cardiac allograft rejection

[1]  Shin-Jeong Lee,et al.  Langerhans cell protein 1 (LCP1) binds to PNUTS in the nucleus: implications for this complex in transcriptional regulation , 2009, Experimental & Molecular Medicine.

[2]  S. Tullius,et al.  Impact of innate and adaptive immunity on rejection and tolerance. , 2008, Transplantation.

[3]  G. Song,et al.  Increased expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in rat cardiac allografts. , 2008, Transplantation proceedings.

[4]  E. Trulock,et al.  Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2005 annual reports. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  M. Teixeira,et al.  Activation of Pro‐Inflammatory and Anti‐Inflammatory Cytokines in Host Organs During Chronic Allograft Rejection: Role of Endothelin Receptor Signaling , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  T. Deuse,et al.  FK778, a novel immunosuppressive agent, reduces early adhesion molecule up‐regulation and prolongs cardiac allograft survival * , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  A. Malik,et al.  cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-kappaB activation and ICAM-1 expression in endothelial cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[8]  O. Griffith,et al.  Non-heme iron protein: A potential target of nitric oxide in acute cardiac allograft rejection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. House,et al.  A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts1 , 2003, Transplantation.

[10]  K. Smetana,et al.  Intercellular cell adhesion molecule‐1 and selectin ligands in acute cardiac allograft rejection: a study on gene‐deficient mouse models , 2002, Journal of leukocyte biology.

[11]  M. Seyfarth,et al.  Blocking caspase-activated apoptosis improves contractility in failing myocardium. , 2001, Human gene therapy.

[12]  W. Suki,et al.  GUIDELINES FOR THE REFERRAL AND MANAGEMENT OF PATIENTS ELIGIBLE FOR SOLID ORGAN TRANSPLANTATION , 2001, Transplantation.

[13]  G. Berry,et al.  Zinc-Mediated Reduction of Apoptosis in Cardiac Allografts , 2000, Circulation.

[14]  T. Starzl,et al.  Donor and recipient leukocytes in organ allografts of recipients with variable donor‐specific tolerance: With particular reference to chronic rejection , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  T. Billiar,et al.  Cyclic Nucleotides Suppress Tumor Necrosis Factor α-Mediated Apoptosis by Inhibiting Caspase Activation and Cytochrome cRelease in Primary Hepatocytes via a Mechanism Independent of Akt Activation* , 2000, The Journal of Biological Chemistry.

[16]  T. Billiar,et al.  Cellular Non-heme Iron Content Is a Determinant of Nitric Oxide-mediated Apoptosis, Necrosis, and Caspase Inhibition* , 2000, The Journal of Biological Chemistry.

[17]  B. McManus,et al.  Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis. , 1999, Circulation.

[18]  J. Soulillou,et al.  Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance. , 1998, Transplantation.

[19]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[20]  B. Kalyanaraman,et al.  Electron spin resonance analysis of heme-nitrosyl and reduced iron-sulfur centered complexes in allogeneic, heterotopic cardiac transplants: effects of treatment with pyrrolidine dithiocarbamate. , 1998, Free radical biology & medicine.

[21]  B. Brüne,et al.  Protease activation during nitric oxide-induced apoptosis: comparison between poly(ADP-ribose) polymerase and U1-70kDa cleavage. , 1998, European journal of pharmacology.

[22]  S. Mustafa,et al.  Expression of Nitric-oxide Synthase in Rat Kupffer Cells Is Regulated by cAMP* , 1998, The Journal of Biological Chemistry.

[23]  T. Billiar,et al.  Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms* , 1997, The Journal of Biological Chemistry.

[24]  A. Namboodiri,et al.  Increasing cAMP Attenuates Induction of Inducible Nitric-oxide Synthase in Rat Primary Astrocytes* , 1997, The Journal of Biological Chemistry.

[25]  T. Starzl,et al.  Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. , 1997, The American journal of pathology.

[26]  R. Michler,et al.  Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. , 1996, Circulation.

[27]  Nigel Mackman,et al.  Elevated Cyclic AMP Inhibits NF-κB-mediated Transcription in Human Monocytic Cells and Endothelial Cells* , 1996, The Journal of Biological Chemistry.

[28]  T. P. Misko,et al.  Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection. , 1996, The Annals of thoracic surgery.

[29]  Y. Asano,et al.  Cyclic AMP augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. , 1996, Journal of molecular and cellular cardiology.

[30]  A. Matsumori,et al.  Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro. , 1996, Clinical immunology and immunopathology.

[31]  P. Macdonald,et al.  Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival. , 1995, Transplantation.

[32]  R. Michler,et al.  Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejection. , 1995, International journal of cardiology.

[33]  Muneesh Tewari,et al.  Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.

[34]  F. J. Fricker,et al.  Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506. , 1995, Journal of the American College of Cardiology.

[35]  D. Adams,et al.  Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. , 1995, Transplantation.

[36]  C. Marboe,et al.  Induction of myocardial nitric oxide synthase by cardiac allograft rejection. , 1994, The Journal of clinical investigation.

[37]  B. Liang,et al.  Reversible contractile dysfunction in reversible experimental cardiac allograft rejection: alterations in the beta-receptor-stimulated adenylylcyclase pathway. , 1993, The Journal of surgical research.

[38]  J. Pober,et al.  Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. , 1993, Journal of immunology.

[39]  J. Balligand,et al.  Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. , 1993, The Journal of clinical investigation.

[40]  P. Neuhaus,et al.  Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. , 1992, The Journal of clinical investigation.

[41]  J. Lancaster,et al.  EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. , 1992, The Journal of biological chemistry.

[42]  T. Starzl,et al.  SUPPRESSION OF ALLOGRAFT REJECTION WITH FK506: I. PROLONGED CARDIAC AND LIVER SURVIVAL IN RATS FOLLOWING SHORT‐COURSE THERAPY , 1990, Transplantation.

[43]  J. Hibbs,et al.  Nitric oxide: a cytotoxic activated macrophage effector molecule. , 1988, Biochemical and biophysical research communications.

[44]  K Ono,et al.  Improved technique of heart transplantation in rats. , 1969, The Journal of thoracic and cardiovascular surgery.